Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02JEW
|
||||
Former ID |
DIB015410
|
||||
Drug Name |
GSK-2130579A
|
||||
Synonyms |
Leukemia vaccine, GlaxoSmithKline; WT1 ASCI, GlaxoSmithKline; WT1 antigen specific cancer immunotherapeutic, GlaxoSmithKline; WT1 vaccine, GlaxoSmithKline
|
||||
Drug Type |
Vaccine
|
||||
Indication | Acute myeloid leukemia [ICD9: 205; ICD10:C92.0] | Phase 1 | [522918] | ||
Company |
Glaxosmithkline
|
||||
Target and Pathway | |||||
Target(s) | Wilms' tumor protein | Target Info | [550079] | ||
KEGG Pathway | Transcriptional misregulation in cancer | ||||
NetPath Pathway | FSH Signaling Pathway | ||||
IL5 Signaling Pathway | |||||
Pathway Interaction Database | p73 transcription factor network | ||||
Regulation of Telomerase | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.